ADVERTISEMENT
Sectors
Get real time update about this post category directly on your device, subscribe now.
Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb
No refractures were reported during long-term follow-up at five years At 24-months post-implantation, 89% of patients achieved bone union Novadip...
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials
Accure to complete required preclinical studies to file IND application for ACT-02 program in 2026 Fonds National de Recherche (FNR) grant will...
Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial
Ella Day | April 1, 2025 | Novo Nordisk announced results from its SOUL cardiovascular outcomes trial. Rybelsus (oral semaglutide)...
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism
Abu Dhabi, United Arab Emirates. February 27, 2025: Cleveland Clinic Abu Dhabi, part of the M42 group, has recorded a...
Sidra Medicine Publishes Impactful Study on Treatable Inherited Metabolic Disorders in Qatar
8 December 2024, Doha, Qatar – A groundbreaking study by Sidra Medicine, a member of Qatar Foundation, has been published...
Recent News
